Search results
The International Nonproprietary Names (INN) Programme is a core activity embedded in the normative functions of WHO and has served the global public health and medicines community fo r over fifty years. The Programme was established to assign nonproprietary names to pharmaceutical substances so that each substance would be recognized by a unique
Lists of Proposed (1–85) and Recommended (1–45) International Nonproprietary Names can be found in Cumulative List No. 10, 2002 (available in CD-ROM only) .The statements indicating action and use are based largely on information supplied by the manufacturer. This information is merely meant to provide an indication of the potential use of ...
Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not imply any recommendation of the use of the substance in medicine or pharmacy. Lists of Proposed (1–117) and Recommended (1–78) International Nonproprietary Names can be found in Cumulative List No. 17, 2017 (available in CD ...
General policies for cell therapy products. During the 55th INN Consultation in 2012, the INN Expert Group decided in principle to name some cell therapy products. A possible INN naming scheme for cell therapy products is currently under development. 4 The definition of recombinant vaccines is given in item 4.23.
Jan 3, 2022 · International Nonproprietary Names (INN) are assigned by the World Health Organization (WHO) to pharmaceutical substances to ensure global recognition by a unique name. INN facilitate safe prescribing through naming consistency, efficient communication and exchange of information, transnational access and pharmacovigilance of medicinal products ...
3.2 General policies for fusion proteins (5) INNs have been assigned to some fusion proteins. If a stem exists for one or the other part of the fusion protein, this stem should be brought into the name. This allows the constant part of a fusion protein to be recognized in the name.
The World Health Organization (WHO) assigns International Nonproprietary Names (INN) to pharmaceutical substances, including advanced therapy medicinal products, to ensure that each substance is globally recognized by a unique name. The majority of INN are published in the WHO Drug Information in ac …
